Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Correction to: Nature Cancer https://doi.org/10.1038/s43018-021-00260-2, published online 29 November 2021.

In the version of this article initially published, there was an error in the author affiliations for Gerson Rothschild and Uttiya Basu. Both authors are affiliated with the Department of Microbiology and Immunology, Columbia University, New York, NY, USA, and not, as originally published, University of Rennes 1. The affiliations have been updated in the HTML and PDF versions of the article.